Approximately One-Third of MS Patients Experiencing Relapses Do Not Adequately ... MarketWatch (press release) The survey included over 2000 patients with MS who had experienced relapses and were treated with either intravenous (IV) or oral corticosteroids. Corticosteroids are generally considered to be first-line therapy for MS relapses requiring therapy by ... |
